Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | MAOA | P21397 | 2/20 | 0.53 |
| ▸ | ATM | Q13315 | 2/20 | 0.53 |
| ▸ | KRAS | P01116 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.50 |
| ▸ | CTSL | P07711 | 1/20 | 0.50 |
| ▸ | CTSB | P07858 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8312374 | 1.00 | CYP1A2 (0.58) | CYP1A2CYP2C19TNFRSF1ASMN1; SMN2ALDH1A1 | |
| SCHEMBL6989989 | 0.81 | TNFRSF1A (0.72) | CYP1A2CYP2C19TNFRSF1ASMN1; SMN2ALDH1A1 | |
| SCHEMBL6989990 | 0.81 | TNFRSF1A (0.72) | CYP1A2CYP2C19TNFRSF1ASMN1; SMN2ALDH1A1 | |
| SCHEMBL27466400 | 0.81 | F3 (0.66) | TNFRSF1AALDH1A1MAOAMAPTMAOB | |
| SCHEMBL11034232 | 0.81 | CA1 (0.53) | CYP1A2SMN1; SMN2ALDH1A1MAOAATM | |
| SCHEMBL1875162 | 0.80 | AKT1 (0.59) | TNFRSF1ASMN1; SMN2ALDH1A1MAPTMAOB | |
| SCHEMBL7529869 | 0.80 | AKT1 (0.59) | TNFRSF1ASMN1; SMN2ALDH1A1MAPTMAOB | |
| SCHEMBL11882381 | 0.80 | AKT1 (0.59) | TNFRSF1ASMN1; SMN2ALDH1A1MAPTMAOB | |
| SCHEMBL956091 | 0.78 | CYP1A2 (0.63) | CYP1A2CYP2C19TNFRSF1ASMN1; SMN2ALDH1A1 | |
| SCHEMBL956092 | 0.78 | CYP1A2 (0.63) | CYP1A2CYP2C19TNFRSF1ASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1601678-A2 | FUSED PYRROLE COMPOUNDS | Synta Pharmaceuticals Corporation (US) | 2005-12-07 | — | — | EP | disclosed |
| US-20050014754-A1 | Fused pyrrole compounds | SYNTA PHARMACEUTICALS CORP. | 2005-01-20 | — | — | US | disclosed |
| WO-2004082606-A2 | FUSED PYRROLE COMPOUNDS | SYNTA PHARMACEUTICALS CORP. (US) | 2004-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014754-A1 | Fused pyrrole compounds | PDE4A, PDE4B, IL4 | CYP1A2 335/4885CYP2C19 322/4885TNFRSF1A 42/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.